Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis with renal involvement
ChiCTR-TRC-10000991Phase 4Completed
- Sponsor
- Ruijin Hospital
- Start
- Jan 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mycophenolate mofetil, cyclophosphamide and prednisone in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) (2 arms), sponsored by Ruijin Hospital. Primary endpoints: Birmingham Vasculitis Activity Score and Renal function. Started Jan 2010; status: completed.
02
Drugs
mycophenolate mofetilcyclophosphamideprednisone
03
Conditions
anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV)
Beyond the preview
Go deeper on ChiCTR-TRC-10000991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000991.